PHS
MYOK

PFM Health Sciences’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

PFM Health Sciences’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-35,592
Closed -$1.67M – 93
2020
Q1 		$1.67M Buy
+35,592
New +$2.28M 0.14% 59
2019
Q4 		– Sell
-1,227,371
Closed -$64M – 89
2019
Q3 		$64M Sell
1,227,371
-550,038
-31% -$29.2M 1.89% 16
2019
Q2 		$89.1M Buy
1,777,409
+176,102
+11% +$8.57M 1.69% 17
2019
Q1 		$83.3M Buy
1,601,307
+63,176
+4% +$2.91M 1.84% 19
2018
Q4 		$75.2M Sell
1,538,131
-340,778
-18% -$18.8M 2% 17
2018
Q3 		$123M Buy
1,878,909
+59,594
+3% +$3.5M 1.79% 12
2018
Q2 		$90.3M Buy
1,819,315
+869,404
+92% +$42.1M 1.41% 18
2018
Q1 		$46.4M Sell
949,911
-343,449
-27% -$17.9M 0.94% 40
2017
Q4 		$54.5M Sell
1,293,360
-323,594
-20% -$12.5M 1.29% 33
2017
Q3 		$69.3M Sell
1,616,954
-52,570
-3% -$1.68M 1.36% 27
2017
Q2 		$21.9M Buy
1,669,524
+131,017
+9% +$1.73M 0.59% 54
2017
Q1 		$20.2M Buy
1,538,507
+13,922
+0.9% +$178K 0.51% 66
2016
Q4 		$19.7M Buy
1,524,585
+331,548
+28% +$5.11M 0.56% 60
2016
Q3 		$19.5M Buy
1,193,037
+354,227
+42% +$6.4M 0.57% 59
2016
Q2 		$10.4M Buy
838,810
+74,178
+10% +$927K 0.31% 69
2016
Q1 		$8.19M Buy
764,632
+65,938
+9% +$600K 0.25% 70
2015
Q4 		$10.2M Buy
+698,694
New +$8.55M 0.31% 55

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PFM Health Sciences's MYOK Position: Q2 2020 in Review

PFM Health Sciences sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 35,592 shares — an estimated $1.67M sold.

PFM Health Sciences first reported a position in MYOK in Q4 2015 and held it in 17 quarters. The position peaked at $123M in Q3 2018. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • PFM Health Sciences reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • PFM Health Sciences sold 35,592 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $1.67M.
  • PFM Health Sciences first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 17 quarters.
  • PFM Health Sciences's MyoKardia, Inc. Common Stock position peaked at $123M in Q3 2018.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.